Literature DB >> 17384671

Optimal primer design using the novel primer design program: MSPprimer provides accurate methylation analysis of the ATM promoter.

J C Brandes1, H Carraway, J G Herman.   

Abstract

Methylation-specific polymerase chain reaction (PCR) (MSP) is frequently used to study gene silencing by promoter hypermethylation. However, non-specific primer design can lead to false-positive detection of methylation. We present a novel, web-based algorithm for the design of primers for bisulfite-PCRs (MSP, sequencing, COBRA and multiplex-MSP), allowing the determination of a specificity score, which is based on the thermodynamic characteristics of the primer 3'-end. PCR amplification with primers not reaching a high specificity score can result in false-positive findings. We used MSPprimer to design MSP primers for analysis of the ATM promoter. In 37 non-small cell lung cancer (NSCLC) samples and 43 breast cancer samples no promoter methylation was detected. Conversely, published MSP primers not reaching the required specificity score led to non-specific amplification of DNA not converted by bisulfite. The result was a false-positive incidence of ATM promoter methylation of 24% in NSCLC and 48% in breast cancers, similar to published studies. This highlights the critical need for specific primer design for MSP. MSPprimer is a convenient tool to achieve this goal, which is available free of charge to the scientific community.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17384671     DOI: 10.1038/sj.onc.1210433

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Generation of Calhm1 knockout mouse and characterization of calhm1 gene expression.

Authors:  Junbing Wu; Shengyi Peng; Rong Wu; Yumin Hao; Guangju Ji; Zengqiang Yuan
Journal:  Protein Cell       Date:  2012-06-21       Impact factor: 14.870

2.  Conformation-selective methylation of geminivirus DNA.

Authors:  T Paprotka; K Deuschle; V Metzler; H Jeske
Journal:  J Virol       Date:  2011-08-10       Impact factor: 5.103

3.  CpG island hypermethylation and repetitive DNA hypomethylation in premalignant lesion of extrahepatic cholangiocarcinoma.

Authors:  Baek-hui Kim; Nam-Yun Cho; So Hyun Shin; Hyeong-Ju Kwon; Ja June Jang; Gyeong Hoon Kang
Journal:  Virchows Arch       Date:  2009-09-10       Impact factor: 4.064

4.  IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers.

Authors:  Tao Fu; Emmanouil P Pappou; Angela A Guzzetta; Marilia de Freitas Calmon; Lifeng Sun; Alexander Herrera; Fan Li; Christopher L Wolfgang; Stephen B Baylin; Christine A Iacobuzio-Donahue; Weidong Tong; Nita Ahuja
Journal:  Ann Surg       Date:  2016-02       Impact factor: 12.969

5.  Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer.

Authors:  Seth A Brodie; Ge Li; Adam El-Kommos; Hyunseok Kang; Suresh S Ramalingam; Madhusmita Behera; Khanjan Gandhi; Jeanne Kowalski; Gabriel L Sica; Fadlo R Khuri; Paula M Vertino; Johann C Brandes
Journal:  Cancer Prev Res (Phila)       Date:  2014-01-17

6.  Functional identification of cancer-specific methylation of CDO1, HOXA9, and TAC1 for the diagnosis of lung cancer.

Authors:  John Wrangle; Emi Ota Machida; Ludmila Danilova; Alicia Hulbert; Noreli Franco; Wei Zhang; Sabine C Glöckner; Mathewos Tessema; Leander Van Neste; Hariharan Easwaran; Kornel E Schuebel; Julien Licchesi; Craig M Hooker; Nita Ahuja; Jun Amano; Steven A Belinsky; Stephen B Baylin; James G Herman; Malcolm V Brock
Journal:  Clin Cancer Res       Date:  2014-01-31       Impact factor: 12.531

7.  Poly(ADP-ribose) polymerase inhibitor CEP-8983 synergizes with bendamustine in chronic lymphocytic leukemia cells in vitro.

Authors:  Robert L Dilley; Weijie Poh; Douglas E Gladstone; James G Herman; Margaret M Showel; Judith E Karp; Michael A McDevitt; Keith W Pratz
Journal:  Leuk Res       Date:  2013-12-30       Impact factor: 3.156

8.  Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumors.

Authors:  Joo Mi Yi; Hsing-Chen Tsai; Sabine C Glöckner; Steven Lin; Joyce E Ohm; Hari Easwaran; C David James; Joseph F Costello; Gregory Riggins; Charles G Eberhart; John Laterra; Angelo L Vescovi; Nita Ahuja; James G Herman; Kornel E Schuebel; Stephen B Baylin
Journal:  Cancer Res       Date:  2008-10-01       Impact factor: 12.701

9.  Whole-exome sequencing of pancreatic neoplasms with acinar differentiation.

Authors:  Yuchen Jiao; Raluca Yonescu; G Johan A Offerhaus; David S Klimstra; Anirban Maitra; James R Eshleman; James G Herman; Weijie Poh; Lorraine Pelosof; Christopher L Wolfgang; Bert Vogelstein; Kenneth W Kinzler; Ralph H Hruban; Nickolas Papadopoulos; Laura D Wood
Journal:  J Pathol       Date:  2014-03       Impact factor: 7.996

10.  Aberrant DNA methylation of integrin alpha4: a potential novel role for metastasis of cholangiocarcinoma.

Authors:  Kyung-Ok Uhm; Jung Ok Lee; Yun Mi Lee; Eun Soo Lee; Hyeon Soo Kim; Sun-Hwa Park
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-05       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.